13-valent pneumococcal conjugate vaccine (multivalent conjugate)
/ Fosun Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 01, 2024
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
(clinicaltrials.gov)
- P3 | N=1800 | Active, not recruiting | Sponsor: Fosun Adgenvax Biopharmaceutical Co.,Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Pneumococcal Infections • Pneumonia
1 to 1
Of
1
Go to page
1